This note using YMC-Triart Bio C4 shows a robust separation at high temperatures for three commercially available mAbs: ofatumumab, palivizumab, and panitumumab.
Streamlining the Analysis of Lipid Mediators with the Extrahera Sample Prep Workstation
September 10th 2024Customer Interview with Antonio Checa, a senior researcher at the Wheelock’s lab at the Karolina Institute describing automating the sample prep workflow in the analysis of lipid mediators such as oxylipinds.